Niccoli, Giampaolo
 Distribuzione geografica
Continente #
NA - Nord America 12.118
EU - Europa 11.597
AS - Asia 8.295
SA - Sud America 1.882
AF - Africa 231
Continente sconosciuto - Info sul continente non disponibili 40
OC - Oceania 31
Totale 34.194
Nazione #
US - Stati Uniti d'America 11.860
DE - Germania 4.973
SG - Singapore 4.107
CN - Cina 2.268
SE - Svezia 1.757
BR - Brasile 1.556
IT - Italia 925
UA - Ucraina 881
FR - Francia 713
GB - Regno Unito 559
IE - Irlanda 513
VN - Vietnam 400
ID - Indonesia 344
FI - Finlandia 304
IN - India 273
RU - Federazione Russa 268
PL - Polonia 182
TR - Turchia 160
AR - Argentina 149
CA - Canada 123
BD - Bangladesh 110
AT - Austria 101
JP - Giappone 98
HK - Hong Kong 94
NL - Olanda 78
IQ - Iraq 76
BE - Belgio 72
MX - Messico 72
ZA - Sudafrica 66
IR - Iran 51
ES - Italia 47
EC - Ecuador 41
MA - Marocco 36
CO - Colombia 35
PK - Pakistan 33
UZ - Uzbekistan 33
KR - Corea 31
EG - Egitto 30
SA - Arabia Saudita 30
EU - Europa 29
VE - Venezuela 29
CZ - Repubblica Ceca 28
CL - Cile 24
LT - Lituania 24
AU - Australia 23
AE - Emirati Arabi Uniti 22
CH - Svizzera 22
IL - Israele 21
KE - Kenya 20
JO - Giordania 19
PE - Perù 18
ET - Etiopia 16
TN - Tunisia 16
RO - Romania 15
GR - Grecia 14
HU - Ungheria 13
JM - Giamaica 13
PY - Paraguay 13
DZ - Algeria 12
KZ - Kazakistan 12
DK - Danimarca 11
AZ - Azerbaigian 10
BG - Bulgaria 10
BY - Bielorussia 10
LV - Lettonia 10
PH - Filippine 10
HN - Honduras 9
HR - Croazia 9
MY - Malesia 9
NO - Norvegia 9
SN - Senegal 9
A2 - ???statistics.table.value.countryCode.A2??? 8
AL - Albania 8
BO - Bolivia 8
CI - Costa d'Avorio 8
CR - Costa Rica 8
DO - Repubblica Dominicana 8
LB - Libano 8
PT - Portogallo 8
UY - Uruguay 8
NP - Nepal 7
PA - Panama 7
PS - Palestinian Territory 7
QA - Qatar 7
RS - Serbia 7
BB - Barbados 6
KG - Kirghizistan 6
NZ - Nuova Zelanda 6
LA - Repubblica Popolare Democratica del Laos 5
MD - Moldavia 5
OM - Oman 5
AM - Armenia 4
CG - Congo 4
CY - Cipro 4
EE - Estonia 4
GE - Georgia 4
KH - Cambogia 4
KW - Kuwait 4
LK - Sri Lanka 4
NI - Nicaragua 4
Totale 34.134
Città #
Chandler 2.430
Singapore 1.923
Ashburn 1.075
San Mateo 516
Dublin 506
New York 492
Beijing 490
Jacksonville 471
Nanjing 337
Jakarta 320
Wilmington 298
Los Angeles 295
Nürnberg 280
Boston 252
Munich 250
Marseille 207
Ann Arbor 203
Dearborn 177
Cattolica 170
Moscow 168
Woodbridge 158
Milan 150
Hefei 149
Lawrence 149
Ho Chi Minh City 143
Rome 141
Frankfurt am Main 137
Houston 136
Princeton 134
Nanchang 133
Dallas 131
Seattle 131
São Paulo 125
Fairfield 123
Warsaw 122
Redwood City 107
Bremen 98
Izmir 98
Hanoi 93
Lancaster 90
Buffalo 84
Hong Kong 83
Helsinki 78
Vienna 78
The Dalles 76
Brussels 71
Tokyo 68
Leawood 64
London 59
Rio de Janeiro 58
Hebei 57
Mountain View 57
Santa Clara 57
Detroit 56
Jiaxing 51
Tianjin 51
Zhengzhou 51
Chicago 50
Turku 50
University Park 49
Düsseldorf 48
Kunming 48
Boardman 47
Norwalk 47
Brooklyn 46
Hangzhou 46
Changsha 45
Nuremberg 45
Shanghai 45
Kent 44
San Francisco 44
Augusta 43
Phoenix 43
Johannesburg 41
Pune 40
Shenyang 40
Andover 38
Denver 38
Kraków 36
Montreal 36
Cambridge 33
Redmond 32
Campinas 31
Stockholm 31
Washington 31
Brasília 30
Chennai 30
Fremont 30
Belo Horizonte 29
Atlanta 28
Baghdad 28
Curitiba 28
Guangzhou 28
Dhaka 27
Tashkent 27
Toronto 27
Lauterbourg 25
Amsterdam 24
Enterprise 24
Manchester 24
Totale 16.083
Nome #
Impact of operator experience and wiring technique on procedural efficacy of trans-radial percutaneous chronic total occlusion recanalization performed by dedicated radialists 285
Coronary microvascular obstruction in acute myocardial infarction 278
Management of the access site after transradial percutaneous procedures: literature overview 254
Comparison of Right and Left Upper Limb Arterial Variants in Patients Undergoing Bilateral Transradial Procedures 251
Different apparent prognostic value of hsCRP in type 2 diabetic and nondiabetic patients with acute coronary syndromes 250
Clinical and procedural impact of aortic arch anatomic variants in carotid stenting procedures 242
Safety and efficacy of G-CSF in patients with ischemic heart failure: The CORNER (Cell Option for Recovery in the Non-Eligible patients for Revascularization) study. 241
Frequency domain optical coherence tomography to assess non-ostial left main coronary artery 233
Prospective evaluation of myocardial ischemia related to post-procedural side-branch stenosis in bifurcated lesions treated by provisional approach with drug-eluting stents. 227
CD4+CD28null T lymphocytes are expanded in young women with polycystic ovary syndrome 226
Renal artery stenting in patients with chronic ischemic heart disease 224
The HEART study: a real-world experience using the CID Chrono Carbostent in primary and rescue PCI 222
Ticagrelor and preconditioning in patients with stable coronary artery disease (TAPER-S): A randomized pilot clinical trial 218
Baseline C-Reactive Protein Serum Levels and In-Stent Restenosis Pattern After m-TOR Inhibitors Drug-Eluting Stent Implantation 216
Euroscore as predictor of in-hospital mortality after percutaneous coronary intervention 209
Management and timing of access-site vascular complications occurring after trans-radial percutaneous coronary procedures 206
Cystatin C is associated with an increased coronary atherosclerotic burden and a stable plaque phenotype in patients with ischemic heart disease and normal glomerular filtration rate 205
Superior vena cava thrombosis treated by angioplasty and stenting in a cirrhotic patient with peritoneovenous shunt 204
Outcome of non-cardiac surgery after stent implantation in the DES era: results of the Surgery After Stent (SAS) registry 195
A case of fatal stent thrombosis after Carbostent implantation: Is clopidogrel alone antiplatelet therapy a safe alternative to aspirin alone antiplatelet therapy 193
Angiographic and clinical outcome of percutaneous coronary intervention for in-stent restenosis of bifurcated lesions 193
Pre-intervention eosinophil cationic protein serum levels predict clinical outcomes following implantation of drug-eluting stents 192
Optical coherence tomography features of angiographic complex and smooth lesions in acute coronary syndromes 186
Vascular complications and access crossover in 10,676 transradial percutaneous coronary procedures 180
Concordance of angiographic and electrocardiographic indexes of microvascular obstruction: myocardial haemorrhage role 178
Euroscore as predictor of in-hospital mortality after percutaneous coronary intervention 177
Procedural and clinical evaluation of the novel zotarolimus-eluting resolute stent in patients with unselected bifurcated coronary stenosis treated by provisional approach: a multicenter registry 176
Angiographic patterns of myocardial reperfusion after primary angioplasty and ventricular remodeling 176
Prospective randomized comparison of sirolimus- or everolimus-eluting stent to treat bifurcated lesions by provisional approach 175
Effect of intensive vs standard statin therapy on endothelial progenitor cells and left ventricular function in patients with acute myocardial infarction: Statins for regeneration after acute myocardial infarction and PCI (STRAP) trial 174
Efficacy of contrast medium induced Pd/Pa ratio in predicting functional significance of intermediate coronary artery stenosis assessed by fractional flow reserve: insights from the RINASCI study 173
Procedural and clinical evaluation of the novel zotarolimus-eluting resolute stent in patients with unselected bifurcated coronary stenosis treated by provisional approach: a multicenter registry 171
Safety of granulocyte-colony-stimulating factor in acute myocardial infarction (the Rigenera study). 169
Eosinophili cationic protein: a new biomarker of coronary atherosclerosis 166
Eosinophil cationic protein and clinical outcome after bare metal stent implantation 165
CD4(+)CD28(null) T lymphocyte frequency, a new marker of cardiovascular risk: relationship with polycystic ovary syndrome phenotypes 164
Angiographically intermediate left main bifurcation disease assessment by frequency domain optical coherence tomography (FD-OCT) 164
Case-control registry of excimer laser coronary angioplasty versus distal protection devices in patients with acute coronary syndromes due to saphenous vein graft disease 163
A current approach to heart failure in Duchenne muscular dystrophy 163
Air Pollution and Coronary Plaque Vulnerability and Instability: An Optical Coherence Tomography Study 162
Impact of gender on clinical outcomes after mTOR-inhibitor drug-eluting stent implantation in patients with first manifestation of ischaemic heart disease 159
Plasma levels of thromboxane A2 on admission are associated with no-reflow after primary percutaneous coronary intervention 159
Drug eluting stent and coronary chronic total occlusions 157
High telomerase activity in neutrophils from unstable coronary plaques 157
Angiographic assessment of myocardial perfusion in Tako-Tsubo syndrome 157
Plaque rupture and intact fibrous cap assessed by optical coherence tomography portend different outcomes in patients with acute coronary syndrome 157
Usefulness of granulocyte colony-stimulating factor in patients with a large anterior wall acute myocardial infarction to prevent left ventricular remodeling (the rigenera study). 156
Concordance of angiographic and electrocardiographic indexes of microvascular obstruction: myocardial haemorrhage role 156
Coronary Atherosclerotic Phenotype and Plaque Healing in Patients with Recurrent Acute Coronary Syndromes Compared with Patients with Long-term Clinical Stability: An in Vivo Optical Coherence Tomography Study 156
Are endothelial progenitor cells mobilized by myocardial ischemia or myocardial necrosis? A cardiac magnetic resonance study 155
Heart failure with preserved ejection fraction diagnosis and treatment: An updated review of the evidence 152
Eosinophil cationic protein and clinical outcome after bare metal stent implantation 151
Coronary bifurcation lesions: to stent one branch or both? A meta-analysis of patients treated with drug eluting stents. 151
Impact of coronary stenting on top of medical therapy and of inclusion of periprocedural infarctions on hard composite endpoints in patients with chronic coronary syndromes: a meta-analysis of randomized controlled trials 151
Efficacy of contrast medium induced Pd/Pa ratio in predicting functional significance of intermediate coronary artery stenosis assessed by fractional flow reserve: insights from the RINASCI study 150
Chlamydia pneumoniae in coronary atherosclerotic plaques and coronary instability 149
Baseline inflammatory status and long-term changes in renal function after percutaneous renal artery stenting: A prospective study 148
Maximal hyperemia in the assessment of fractional flow reserve: intracoronary adenosine versus intracoronary sodium nitroprusside versus intravenous adenosine: the NASCI (Nitroprussiato versus Adenosina nelle Stenosi Coronariche Intermedie) study 147
Effects of late REopening of Coronary total Occlusion on micRovascular perfusion and myocarDial function: the RECORD study 147
CagA antigen of Helicobacter pylori and coronary instability: insight from a clinico-pathological study and a meta-analysis of 4241 cases 146
Resolute zotarolimus-eluting stent to treat bifurcated lesions according to the provisional technique: a procedural performance comparison with sirolimus- and everolimus-eluting stents 146
Three-dimensional quantitative coronary angiography and quantification of jeopardised myocardium to predict functional significance of intermediate coronary artery stenosis 146
Frequency-domain optical coherence tomography findings in patients with bifurcated lesions undergoing provisional stenting 145
Coronary atherosclerotic burden in patients with infection by CagA-positive strains of Helicobacter pylori 143
Hypotestosteronemia is frequent in ST-elevation myocardial infarction patients and is associated with coronary microvascular obstruction 143
The 9p21 Rs 1333040 polymorphism is associated with coronary microvascular obstruction in ST-segment elevation myocardial infarction treated by primary angioplasty 143
No-reflow: incidence and detection in the cath-lab 142
Association between C-reactive protein and angiographic restenosis after bare metal stents: an updated and comprehensive meta-analysis of 2747 patients 141
Chlamydia pneumoniae in coronary atherosclerotic plaques and coronary instability 141
EuroSCORE predicts long-term mortality of unselected patients undergoing percutaneous coronary interventions 141
Predictors of thromboxane levels in patients with non-ST-elevation acute coronary syndromes on chronic aspirin therapy 141
Parvovirus B19 at the culprit coronary stenosis predicts outcome after stenting 141
Correlation between CD4 + CD28 null T lymphocytes, regulatory T cells and plaque rupture: An Optical Coherence Tomography study in Acute Coronary Syndromes 141
EuroSCORE predicts long-term mortality of unselected patients undergoing percutaneous coronary interventions 141
Clinical, angiographic and echocardiographic correlates of epicardial and microvascular spasm in patients with myocardial ischaemia and non-obstructive coronary arteries 141
High levels of systemic myeloperoxidase are associated with coronary plaque erosion in patients with acute coronary syndromes: a clinicopathological study 140
Influence of the amount of myocardium subtended by a stenosis on fractional flow reserve 140
Interplay Between Myocardial Bridging and Coronary Spasm in Patients With Myocardial Ischemia and Non-Obstructive Coronary Arteries: Pathogenic and Prognostic Implications 140
Three-dimensional quantitative coronary angiography and quantification of jeopardised myocardium to predict functional significance of intermediate coronary artery stenosis 139
A meta-analysis of first-generation drug-eluting vs bare-metal stents for coronary chronic total occlusion: effect of length of follow-up on clinical outcome 138
Impact of drug-eluting balloon (pre- or post-) dilation on neointima formation in de novo lesions treated by bare-metal stent: the IN-PACT CORO trial 138
Laser for complex coronary lesions: impact of excimer lasers and technical advancements 135
Outcome of overlapping heterogenous drug-eluting stents and of overlapping drug-eluting and bare metal stents. 135
Ethanol abolishes ischemic preconditioning in humans 134
Serum levels of γ-glutamyltransferase and progression of coronary atherosclerosis 134
Alterations of Hyaluronan Metabolism in Acute Coronary Syndrome: Implications for Plaque Erosion 134
The Same Angiographic Factors Predict Venous and Arterial Graft Patency: A Retrospective Study 132
Endothelial progenitor cells, microvascular obstruction, and left ventricular remodeling in patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention 132
ORal anticoagulants In fraGile patients with percutAneous endoscopic gastrostoMy and atrIal fibrillation: the (ORIGAMI) study 132
Effects of drospirenone-ethinylestradiol and/or metformin on CD4(+)CD28(null) T lymphocytes frequency in women with hyperinsulinemia having polycystic ovary syndrome: a randomized clinical trial. 131
Management and timing of access-site vascular complications occurring after trans-radial percutaneous coronary procedures 131
Association between inflammatory biomarkers and in-stent restenosis tissue features: an Optical Coherence Tomography Study 130
Predictors of periprocedural (type IVa) myocardial infarction, as assessed by frequency-domain optical coherence tomography 129
Radial artery complications occurring after transradial coronary procedures using long hydrophilic-coated introducer sheath: a frequency domain-optical coherence tomography study 129
The central role of conventional 12-lead ECG for the assessment of microvascular obstruction after percutaneous myocardial revascularization 129
Frequency-domain optical coherence tomography assessment of kissing-balloon effects in bifurcated coronary artery lesions undergoing provisional stenting 128
Spontaneous coronary dissection as cause of recurring myocardial infarction. 127
[Clinical value of inflammatory biomarkers after stent implantation] 127
Role of Allergic Inflammatory Cells in Coronary Artery Disease 127
No-reflow reversibility: a study based on serial assessment of multiple biomarkers 126
Totale 16.560
Categoria #
all - tutte 146.485
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 146.485


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.214 0 0 0 0 0 135 267 77 287 77 307 64
2021/20222.881 174 194 50 178 132 91 81 505 115 212 542 607
2022/20236.065 764 900 571 955 268 797 274 459 744 87 161 85
2023/20242.757 116 767 90 109 91 553 155 87 57 83 334 315
2024/20255.195 121 220 406 228 491 130 156 269 790 460 1.113 811
2025/20267.357 2.137 358 711 1.409 2.328 414 0 0 0 0 0 0
Totale 34.663